company background image
TWST

Twist Bioscience NasdaqGS:TWST Stock Report

Last Price

US$25.44

Market Cap

US$1.4b

7D

2.5%

1Y

-73.2%

Updated

27 Nov, 2022

Data

Company Financials +
TWST fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

TWST Stock Overview

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products.

Twist Bioscience Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Twist Bioscience
Historical stock prices
Current Share PriceUS$25.44
52 Week HighUS$99.74
52 Week LowUS$23.90
Beta1.14
1 Month Change-23.79%
3 Month Change-36.76%
1 Year Change-73.22%
3 Year Change6.76%
5 Year Changen/a
Change since IPO81.71%

Recent News & Updates

Recent updates

Twist Bioscience (NASDAQ:TWST) Has Debt But No Earnings; Should You Worry?

Jan 04
Twist Bioscience (NASDAQ:TWST) Has Debt But No Earnings; Should You Worry?

Is Twist Bioscience (NASDAQ:TWST) Using Too Much Debt?

Sep 21
Is Twist Bioscience (NASDAQ:TWST) Using Too Much Debt?

Twist Bioscience (NASDAQ:TWST) Is Using Debt Safely

May 10
Twist Bioscience (NASDAQ:TWST) Is Using Debt Safely

Shareholder Returns

TWSTUS BiotechsUS Market
7D2.5%0.4%1.3%
1Y-73.2%-14.4%-18.5%

Return vs Industry: TWST underperformed the US Biotechs industry which returned -14.4% over the past year.

Return vs Market: TWST underperformed the US Market which returned -18.5% over the past year.

Price Volatility

Is TWST's price volatile compared to industry and market?
TWST volatility
TWST Average Weekly Movement14.3%
Biotechs Industry Average Movement11.1%
Market Average Movement7.4%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market3.3%

Stable Share Price: TWST is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 14% a week.

Volatility Over Time: TWST's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2013652Emily Leprousthttps://www.twistbioscience.com

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company’s DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium.

Twist Bioscience Corporation Fundamentals Summary

How do Twist Bioscience's earnings and revenue compare to its market cap?
TWST fundamental statistics
Market CapUS$1.43b
Earnings (TTM)-US$217.86m
Revenue (TTM)US$203.57m

7.0x

P/S Ratio

-6.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
TWST income statement (TTM)
RevenueUS$203.57m
Cost of RevenueUS$119.33m
Gross ProfitUS$84.24m
Other ExpensesUS$302.10m
Earnings-US$217.86m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-3.87
Gross Margin41.38%
Net Profit Margin-107.02%
Debt/Equity Ratio0%

How did TWST perform over the long term?

See historical performance and comparison